Showing results (741-750 of 990) with videos related to

Sort By:
Pageof 99
Allergy|July 9, 2004
The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadineJ Bousquet, C Bindslev-Jensen, G W Canonica, et al.
The European Respiratory Journal|December 2, 2004
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPDA M Vignola, F Paganin, L Capieu, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 1998
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitisA M Vignola, L Riccobono, A Mirabella, et al.
Allergy|February 6, 2010
Is physician-diagnosed allergic rhinitis a risk factor for the development of asthma?L van den Nieuwenhof, T Schermer, Y Bosch, et al.
Revue D'Epidemiologie Et De Sante Publique|June 4, 2017
[Using cancer case identification algorithms in medico-administrative databases: Literature review and first results from the REDSIAM Tumors group based on breast, colon, and lung cancer]P-J Bousquet, P Caillet, M Coeuret-Pellicer, et al.
BMC Health Services Research|January 23, 2015
Comparison of two methods to report potentially avoidable hospitalizations in France in 2012: a cross-sectional studyRodolphe Bourret, Grégoire Mercier, Jacques Mercier, et al.
The European Respiratory Journal|January 1, 1996
Comparison of an expert system with other clinical scores for the evaluation of severity of asthmaV Gautier, H Rédier, J L Pujol, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2006
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthmaGiovanni Passalacqua, Philippe J Bousquet, Kai-Hakon Carlsen, et al.
Respiratory Medicine|August 2, 2000
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial)L Bjermer, H Bisgaard, J Bousquet, et al.
Allergy|February 1, 2005
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthmaJ Bousquet, P Cabrera, N Berkman, et al.
Pageof 99